Neogenomics Inc (NEO.OQ)

NEO.OQ on NASDAQ Stock Exchange Capital Market

22 Nov 2017
Change (% chg)

$0.12 (+1.33%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chart for


NeoGenomics, Inc. is an operator of a network of cancer-focused genetic testing laboratories. The Company operates in Laboratory Testing Segment. This segment delivers testing services to hospitals, pathologists, oncologists, other clinicians and researchers. It has laboratory locations in Ft. Myers and Tampa, Florida; Aliso... (more)


Beta: 0.92
Market Cap(Mil.): $876.44
Shares Outstanding(Mil.): 79.39
Dividend: --
Yield (%): --


BRIEF-Neogenomics Inc files for non-timely 10-Q - SEC filing ‍​

* Neogenomics Inc files for non-timely 10-Q - SEC filing ‍​ Source text: (http://bit.ly/2AozWFk) Further company coverage:

10 Nov 2017

BRIEF-NeoGenomics reports Q3 adj earnings per share of $0.01

* NeoGenomics reports revenue of $63.1 million on 17 percent volume growth and 11 percent reduction in average cost per test in the third quarter of 2017

25 Oct 2017

BRIEF-NeoGenomics sees Q3 revenue of about $63.1 mln

* NeoGenomics announces preliminary quarter 3 results, financial impacts of hurricanes and summary quarter 4 guidance

13 Oct 2017

BRIEF-Neogenomics reports on impact from hurricane Irma

* Hurricane Irma had minimal impacts to Fort Myers, FL facility​

12 Sep 2017

BRIEF-Neogenomics announces expansion of its immuno-oncology profiling test menu

* Announced an expansion of its immuno-oncology profiling test menu

02 Jun 2017

Earnings vs. Estimates